Literature DB >> 7796805

Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations.

C Chen1, V A Roberts, S Stevens, M Brown, M P Stenzel-Poore, M B Rittenberg.   

Abstract

We examined the positive and negative effects of somatic mutation on antibody function using saturation mutagenesis in vitro to mimic the potential of the in vivo process to diversify antibodies. Identical mutations were introduced into the second complementarity determining region of two anti-phosphocholine antibodies, T15 and D16, which share the same germline VH gene sequence. T15 predominates in primary responses and does not undergo affinity maturation. D16 is representative of antibodies that co-dominate in memory responses and do undergo affinity maturation. We previously reported that > 50% of T15 mutants had decreased antigen binding capacity. To test if this high frequency of binding loss was unique to T15 or a consequence of random point mutations applicable to other combining sites, we analyzed the same mutations in D16. We show that D16 suffers a similar loss of function, indicating an equally high potential for B-cell wastage. However, only D16 displayed the capacity for somatic mutation to improve antigen binding, which should enhance its persistence in memory responses. Mutation of residues contacting the haptenic group, as determined by molecular modeling, did not improve binding. Instead, productive mutations occurred in residues that either contacted carrier protein or were distant from the antigen binding site, possibly increasing binding site flexibility through long-range effects. Targeting such residues for mutation should aid in the rational design of improved antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796805      PMCID: PMC398397          DOI: 10.1002/j.1460-2075.1995.tb07278.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

2.  Identification of mutant monoclonal antibodies with increased antigen binding.

Authors:  R R Pollock; D L French; M L Gefter; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Clonal restriction of the immune response to phosphorylcholine.

Authors:  W Lee; H Cosenza; H Köhler
Journal:  Nature       Date:  1974-01-04       Impact factor: 49.962

Review 4.  Evolutionary and somatic selection of the antibody repertoire in the mouse.

Authors:  K Rajewsky; I Förster; A Cumano
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

5.  Immune response to phosphorylcholine. I. Characterization of the epitope-specific antibody.

Authors:  L Kluskens; W Lee; H Köhler
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

6.  Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies.

Authors:  J L Claflin; R Lieberman; J M Davie
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

7.  Antibody response to phosphorylcholine in vitro. II. Analysis of T-dependent and T-independent responses.

Authors:  J Quintáns; H Cosenza
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

8.  Immunologic memory to phosphorylcholine. II. PC-KLH induces two antibody populations that dominate different isotypes.

Authors:  S P Chang; M Brown; M B Rittenberg
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.

Authors:  C Chen; T M Martin; S Stevens; M B Rittenberg
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors.

Authors:  L A Herzenberg; S J Black; T Tokuhisa; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  7 in total

1.  In vitro scanning saturation mutagenesis of an antibody binding pocket.

Authors:  E A Burks; G Chen; G Georgiou; B L Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Single amino acid substitution in LC-CDR1 induces Russell body phenotype that attenuates cellular protein synthesis through eIF2α phosphorylation and thereby downregulates IgG secretion despite operational secretory pathway traffic.

Authors:  Haruki Hasegawa; Ann Hsu; Christine E Tinberg; Karen E Siegler; Aaron A Nazarian; Mei-Mei Tsai
Journal:  MAbs       Date:  2017-04-05       Impact factor: 5.857

3.  Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.

Authors:  H E Baxendale; D Goldblatt
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Authors:  Q S Mi; L Zhou; D H Schulze; R T Fischer; A Lustig; L J Rezanka; D M Donovan; D L Longo; J J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.

Authors:  Yifang Chen; Yong-Beom Park; Ekta Patel; Gregg J Silverman
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  The structural basis of repertoire shift in an immune response to phosphocholine.

Authors:  M Brown; M A Schumacher; G D Wiens; R G Brennan; M B Rittenberg
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

7.  The structural repertoire of the human V kappa domain.

Authors:  I M Tomlinson; J P Cox; E Gherardi; A M Lesk; C Chothia
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.